| LP | labile peptide; labile protein; laboratory procedure; lactic peroxidase; lamina propria; laryngophar... |
|---|---|
| L/P | lactate/pyruvate [ratio]; liver plasma [concentration]; lymph/plasma [ratio] |
| PA | panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'... |
| PC | avoirdupois weight [Lat. pondus civile]; packed cells; paper chromatography; paracortex; parent cell... |
| PG | paregoric; parotid gland; pentagastrin; pepsinogen; peptidoglycan; Pharmacopoeia Germanica; phosphat... |
| plasma therapy | Treatment with plasma. (05 Mar 2000) |
|---|---|
| plasma thromboplastin antecedent | <chemical> Stable blood coagulation factor involved in the intrinsic pathway. The activated form xia activates factor ix to ixa. Deficiency of factor xi is often called haemophilia c. Chemical name: Blood-coagulation factor XI (12 Dec 1998) |
| plasma thromboplastin component | <chemical> Storage-stable blood coagulation factor acting in the intrinsic pathway. Its activated form, ixa, forms a complex with factor viii and calcium on platelet factor 3 to activate factor x to xa. Deficiency of factor ix results in christmas disease (haemophilia b). Chemical name: Blood-coagulation factor IX (12 Dec 1998) |
| plasma thromboplastin factor | A coagulation (clotting) factor. Classic haemophilia (haemophilia A) is due to a congenital deficiency in the amount (or activity) of factor VIII. Factor VIII is also known as antihemophiliac factor (AHF) or antihemophiliac globulin (AHG). The gene for factor VIII (that for classic haemophilia) is on the X chromosome so females can be silent carriers without symptoms and males can be haemophiliacs. (12 Dec 1998) |
| plasma thromboplastin factor B | <chemical> Storage-stable blood coagulation factor acting in the intrinsic pathway. Its activated form, ixa, forms a complex with factor viii and calcium on platelet factor 3 to activate factor x to xa. Deficiency of factor ix results in christmas disease (haemophilia b). Chemical name: Blood-coagulation factor IX (12 Dec 1998) |
| plasma volume | Volume of plasma in the circulation. It is usually measured by indicator dilution techniques. (12 Dec 1998) |
| plasma wave | <physics> A disturbance of a plasma away from equilibrium, involving oscillations of the plasma's constituent particles and of an electromagnetic field. Plasma waves can propagate from one point in the plasma to another without net motion of the plasma. (09 Oct 1997) |
| muscle plasma | An alkaline fluid in muscle that is spontaneously coagulable, separating into myosin and muscle serum. (05 Mar 2000) |
| core plasma | <radiobiology> Hot plasma at the centre of a fusion reactor, distinguished from edge plasma and scrape-off layer (SOL). The core plasma does not directly feel the effects of the divertor or limiter in the way the edge plasma does. (09 Oct 1997) |
| pregnancy-associated alpha-plasma protein | An alpha 2-macroglobulin, molecular weight approximately 750,000 now believed to be a pregnancy-specific protein. Its plasma levels increase steadily during the second trimester and continue to rise until the end of gestation. (12 Dec 1998) |
| pregnancy-associated beta-plasma protein | A beta-globulin now believed to be a pregnancy-specific protein. Its plasma levels increase steadily during pregnancy until the end of gestation. (12 Dec 1998) |
| salted plasma | The fluid portion of blood drawn from the vessels, which is prevented from coagulating by being drawn into a solution of sodium or magnesium sulfate. Synonym: salted serum. (05 Mar 2000) |
| human plasma protein fraction | A sterile solution of selected proteins derived from the blood plasma of adult human donors, containing 4.5 to 5.5 g of protein per 100 ml, of which 83 to 90% is albumin and the remainder is alpha-and beta-globulins; used as a blood volume supporter. (05 Mar 2000) |
| standing plasma test | If plasma is stored at 4캜 upright in a test tube, chylomicrons will float to the top and form a creamy layer. (05 Mar 2000) |
| normal human plasma | Sterile plasma obtained by pooling approximately equal amounts of the liquid portion of citrated whole blood from eight or more adult humans who have been certified as free from any disease which is tranmissible by transfusion, and treating it with ultraviolet irradiation to destroy possible bacterial and viral contaminants. (05 Mar 2000) |